Verrica Pharmaceuticals Inc. (VRCA) Return on equity 2021–2025
Verrica Pharmaceuticals Inc. (VRCA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-72.3%FY2025 · since FY2021: -107.6% → -72.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -72.3% | — |
| FY2023 | -339.0% | -277.8 pp |
| FY2022 | -61.2% | +46.4 pp |
| FY2021 | -107.6% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More VRCA financial trends
VRCA RevenueVRCA Net incomeVRCA Net marginVRCA Gross profitVRCA Gross marginVRCA Operating incomeVRCA Operating marginVRCA Operating cash flowVRCA Free cash flowVRCA Capital expendituresVRCA Stock buybacksVRCA Dividends paidVRCA Total assetsVRCA Total liabilitiesVRCA Shareholders’ equityVRCA overview →